drugset / Trial / NCT01511640

Behavioral Effects of Pregabalin and Cannabis

NCT01511640

Phase 0 Completed 30 enrolled University of Kentucky
RandomizedCrossoverDouble-blindBasic science

Summary

Cannabis is the most commonly used illicit drug in the United States, and its use is associated with rates of development of abuse and dependence, treatment admission and relapse that are comparable to other illicit drugs. Currently there is no effective pharmacological treatment for cannabis-use disorders. The purpose of the present study is to evaluate the ability of pregabalin to reduce cannabis use thereby evaluating its effectiveness as a medication for cannabis-use disorders.

Timeline

Start
2017-02-01
Primary completion
2020-03-15
Completion
2020-03-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule